BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 03, 2023 at 09:45 am EDT
Share
BioForce Nanosciences Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.113607 million compared to USD 0.122587 million a year ago.
For the nine months, net loss was USD 0.357543 million compared to USD 0.370779 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Companyâs Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Companyâs wholly owned subsidiary is Element Global, Inc.
BIOFORCE NANOSCIENCES HOLDINGS, INC. 
